肝病指南

订阅

MedSci主页 / 所有栏目 / 肝病指南

2021 SMFM咨询系列#56：妊娠期丙型肝炎管理指南

2021-09-02 母胎医学会 World Journal of Emergency Surgery

妊娠期丙型肝炎

2021年9月，母胎医学会(SMFM)发布了妊娠期丙型肝炎的管理指南，用以替代2017年第43号文件。丙型肝炎病毒在母婴之间传播的风险约为5%，妊娠期感染丙型肝炎病毒与不良胎儿结局的风险增加有关。

中文标题：

2021 SMFM咨询系列#56：妊娠期丙型肝炎管理指南

英文标题：

Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy-updated guidelines: Replaces Consult Number 43, November 2017

发布机构：

母胎医学会

发布日期：

2021-09-02

简要介绍：

2021年9月，母胎医学会(SMFM)发布了妊娠期丙型肝炎的管理指南，用以替代2017年第43号文件。丙型肝炎病毒在母婴之间传播的风险约为5%，妊娠期感染丙型肝炎病毒与不良胎儿结局的风险增加有关。本文主要针对妊娠期丙型肝炎的筛查、复查以及治疗的相关内容提供最新指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=1-s2.0-S0002937821006396-main.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3d9481c00219329e, title=2021 SMFM咨询系列#56：妊娠期丙型肝炎管理指南, enTitle=Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy-updated guidelines: Replaces Consult Number 43, November 2017, guiderFrom= World Journal of Emergency Surgery, authorId=0, author=, summary=2021年9月，母胎医学会(SMFM)发布了妊娠期丙型肝炎的管理指南，用以替代2017年第43号文件。丙型肝炎病毒在母婴之间传播的风险约为5%，妊娠期感染丙型肝炎病毒与不良胎儿结局的风险增加有关。, cover=https://img.medsci.cn/2021925/1632582322763_5579292.jpg, journalId=0, articlesId=null, associationId=951, associationName=母胎医学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Sep 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年9月，母胎医学会(SMFM)发布了妊娠期丙型肝炎的管理指南，用以替代2017年第43号文件。丙型肝炎病毒在母婴之间传播的风险约为5%，妊娠期感染丙型肝炎病毒与不良胎儿结局的风险增加有关。本文主要针对妊娠期丙型肝炎的筛查、复查以及治疗的相关内容提供最新指导建议。</span></p>, tagList=[TagDto(tagId=115247, tagName=妊娠期丙型肝炎)], categoryList=[CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=589, guiderKeyword=丙型肝炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=19145, appHits=74, showAppHits=0, pcHits=508, showPcHits=19070, likes=1, shares=11, comments=16, approvalStatus=1, publishedTime=Sat Sep 25 23:11:02 CST 2021, publishedTimeString=2021-09-02, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Sep 25 23:08:17 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 12:05:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1-s2.0-S0002937821006396-main.pdf)])
1-s2.0-S0002937821006396-main.pdf
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192964, encodeId=3b0b1192964ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/850a5482eea148de8fc4ef7a60a6a5bc/4914dc94ed344c4a90575ec4687755d3.jpg, createdBy=d9705449866, createdName=p p p, createdTime=Sun Feb 13 14:42:01 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069991, encodeId=57421069991d1, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b4c4790340, createdName=xumeiling, createdTime=Sat Nov 13 21:46:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059115, encodeId=a8f5105911523, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Sun Oct 10 08:26:14 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057375, encodeId=9974105e37542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70e95598752, createdName=ms5000000928226757, createdTime=Mon Oct 04 08:20:43 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054903, encodeId=73de10549031c, content=有收获；继续加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Sun Sep 26 10:02:48 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2022-02-13 p p p

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192964, encodeId=3b0b1192964ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/850a5482eea148de8fc4ef7a60a6a5bc/4914dc94ed344c4a90575ec4687755d3.jpg, createdBy=d9705449866, createdName=p p p, createdTime=Sun Feb 13 14:42:01 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069991, encodeId=57421069991d1, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b4c4790340, createdName=xumeiling, createdTime=Sat Nov 13 21:46:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059115, encodeId=a8f5105911523, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Sun Oct 10 08:26:14 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057375, encodeId=9974105e37542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70e95598752, createdName=ms5000000928226757, createdTime=Mon Oct 04 08:20:43 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054903, encodeId=73de10549031c, content=有收获；继续加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Sun Sep 26 10:02:48 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-11-13 xumeiling

    正需要

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192964, encodeId=3b0b1192964ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/850a5482eea148de8fc4ef7a60a6a5bc/4914dc94ed344c4a90575ec4687755d3.jpg, createdBy=d9705449866, createdName=p p p, createdTime=Sun Feb 13 14:42:01 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069991, encodeId=57421069991d1, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b4c4790340, createdName=xumeiling, createdTime=Sat Nov 13 21:46:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059115, encodeId=a8f5105911523, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Sun Oct 10 08:26:14 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057375, encodeId=9974105e37542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70e95598752, createdName=ms5000000928226757, createdTime=Mon Oct 04 08:20:43 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054903, encodeId=73de10549031c, content=有收获；继续加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Sun Sep 26 10:02:48 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-10-10 泡泡糖111

    努力学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1192964, encodeId=3b0b1192964ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/850a5482eea148de8fc4ef7a60a6a5bc/4914dc94ed344c4a90575ec4687755d3.jpg, createdBy=d9705449866, createdName=p p p, createdTime=Sun Feb 13 14:42:01 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069991, encodeId=57421069991d1, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b4c4790340, createdName=xumeiling, createdTime=Sat Nov 13 21:46:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059115, encodeId=a8f5105911523, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Sun Oct 10 08:26:14 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057375, encodeId=9974105e37542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70e95598752, createdName=ms5000000928226757, createdTime=Mon Oct 04 08:20:43 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054903, encodeId=73de10549031c, content=有收获；继续加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Sun Sep 26 10:02:48 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-10-04 ms5000000928226757

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1192964, encodeId=3b0b1192964ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/850a5482eea148de8fc4ef7a60a6a5bc/4914dc94ed344c4a90575ec4687755d3.jpg, createdBy=d9705449866, createdName=p p p, createdTime=Sun Feb 13 14:42:01 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069991, encodeId=57421069991d1, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b4c4790340, createdName=xumeiling, createdTime=Sat Nov 13 21:46:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059115, encodeId=a8f5105911523, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Sun Oct 10 08:26:14 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057375, encodeId=9974105e37542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70e95598752, createdName=ms5000000928226757, createdTime=Mon Oct 04 08:20:43 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054903, encodeId=73de10549031c, content=有收获；继续加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Sun Sep 26 10:02:48 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-26 老龙一点

    有收获；继续加油

    0

以上为热门评论，梅斯医学App还有更多内容

拓展阅读

2014 EASL 丙型肝炎诊疗推荐建议

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2014-04-11

2014 英国指南共识：丙型肝炎的管理和直接抗病毒治疗

外国肝病科相关专家小组（统称） · 2014-04-22

2015 CASL共识指南：慢性丙型肝炎的管理（更新版）

加拿大肝病学会(CASL,Cannadian Association for the Study of the Liver) · 2015-01-13

丙型肝炎防治指南(2015更新版)

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-04-20

2016年APASL共识建议：丙型肝炎的治疗

亚太肝脏研究学会(APASL,Asian-Pacific Association for the Study of the Liver) · 2016-06-08

丙型肝炎直接抗病毒药物临床试验评价专家建议

中国肝病科相关专家小组（统称） · 2016-06-08